Linear IgA bullous dermatosis
Linear IgA bullous dermatosis is a rare immune-mediated blistering skin disease frequently associated with medication exposure, especially vancomycin, with men and women being equally affected.[6] Skin lesions typically occur in a wide range of locations, including the hands, feet, genitalia, trunk, and face, especially the perioral area.Adults experience a lower incidence of developing annular lesions exhibiting peripheral vesiculation compared to children.[13] There have also been reports of localized variations of LABD that manifest as annular inflammatory plaques or restricted blistering eruptions.[24] Many case reports have documented the incidence of LABD in conjunction with solid organ cancers and lymphoproliferative diseases.[39][40] IgA antibodies directed against various basement membrane antigens, such as type VII collagen (COL7), laminin-332, or laminin gamma 1, are present in certain patients with LABD.[10] Linear IgA bullous dermatosis histopathologic features are vague and frequently mimic dermatitis herpetiformis.[10] First-line treatment for LABD is thought to be dapsone, an immunomodulatory sulfone that has been successfully used to treat a variety of dermatologic illnesses marked by neutrophilic infiltrates.